Regenerating Tissue. Transforming Healthcare.
Under the slogan ‘A Company That Cares for People and Health,’ we are accelerating the development of therapeutics, starting with treatments for musculoskeletal disorders and expanding into therapies for target diseases such as diabetes and obesity. The Biologics sector is a rapidly growing field worldwide, with an average annual market growth of over 20%. Compared to synthetic drugs, biologics have already been recognized in both academia and industry as more effective for treating severe diseases, with fewer side effects and greater safety.
We aspire to lead the world in developing next-generation microbial drug materials—growth factor biobetters—and in advancing the field of alternative vaccine engineering.
Becoming a Global LeaderWe aspire to lead the world in developing next-generation microbial drug materials—growth factor biobetters—and in advancing the field of alternative vaccine engineering.
Starting with therapies for musculoskeletal disorders, we are committed to developing treatments for diabetes and obesity, dedicating ourselves to research and innovation for the health and well-being of all
For People and HealthStarting with therapies for musculoskeletal disorders, we are committed to developing treatments for diabetes and obesity, dedicating ourselves to research and innovation for the health and well-being of all
With continuous creativity and innovation, we are committed to achieving excellence through groundbreaking research and development
Creative Research & DevelopmentWith continuous creativity and innovation, we are committed to achieving excellence through groundbreaking research and development
Our vision is to leverage advanced synthetic biology to regenerate tissue and treat degenerative diseases, while at the same time transforming healthcare with disease-modifying therapeutics that reduce the burden on society.
We aim to transform the treatment of age-related degeneration by developing regenerative therapies that restore tissue function rather than merely alleviating symptoms. By targeting the root causes of conditions like osteoarthritis and spinal degeneration, these therapies can improve quality of life for patients and families, help maintain independence, and extend healthy lifespans. At the same time, they have the potential to reduce the societal and healthcare burden by decreasing the need for chronic medications, repeated surgeries, and long-term care.
Under the slogan 'Curing Better Than Mother Nature,’ we are accelerating the development of therapeutics, starting with treatments for musculoskeletal disorders and expanding into therapies for target diseases such as diabetes and obesity. The Biologics sector is a rapidly growing field worldwide, with an average annual market growth of over 20%. Compared to synthetic drugs, biologics have already been recognized in both academia and industry as more effective for treating severe diseases, with fewer side effects and greater safety.
Curing Better Than Mother Nature™
We aspire to lead the world in developing next-generation microbial drug materials—growth factor biobetters—and in advancing the field of alternative vaccine engineering.
Becoming a Global LeaderWe aspire to lead the world in developing next-generation microbial drug materials—growth factor biobetters—and in advancing the field of alternative vaccine engineering.
Starting with therapies for musculoskeletal disorders, we are committed to developing treatments for diabetes and obesity, dedicating ourselves to research and innovation for the health and well-being of all
For People and HealthStarting with therapies for musculoskeletal disorders, we are committed to developing treatments for diabetes and obesity, dedicating ourselves to research and innovation for the health and well-being of all
With continuous creativity and innovation, we are committed to achieving excellence through groundbreaking research and development
Creative Research & DevelopmentWith continuous creativity and innovation, we are committed to achieving excellence through groundbreaking research and development
